TrialLupus science & medicine2022

Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial.

Stephen McDonald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.